Liu AI-ECG (AF & anticoagulation)
2025
Artificial Intelligence-Enabled ECGs for Atrial Fibrillation Identification and Enhanced Oral Anticoagulant Adoption: a Pragmatic Randomized Clinical Trial
In 17,817 emergency and hospitalised patients treated by non-cardiologists, an AI-ECG atrial fibrillation alert to the treating physician increased NOAC prescription within 90 days of discharge compared with usual care.
Result
Efficacy: NOAC prescription within 90 days after discharge (co-primary with new AF diagnosis, echocardiogram arrangement and cardiologist visits)HR 1.85 (95% CI 1.11-3.07)
Below 1 favours usual care, above 1 favours an AI-ECG atrial fibrillation alert to the treating physician.
- Absolute difference
- 11.3 points
- NNT
- 9
Absolute difference and NNT are derived from the event rates.
Also reported: New AF diagnosis HR 1.40 (95% CI 1.03–1.90); no significant difference in echocardiograms, cardiologist visits, ischaemic stroke, cardiovascular or all-cause death. 275 vs 245 patients had AI-detected AF.
- Subtopic
- Atrial fibrillation
- Design
- Open-label cluster RCT (120 vs 113 non-cardiologists randomised), two hospitals, Taiwan
- Relevance
- Supporting: context rather than must-know.
- Source
- Liu WT, et al. J Am Heart Assoc. 2025;14(14):e042106.doi 10.1161/JAHA.125.042106
Discussion & critique
Targets the treatment gap rather than detection alone: an AI-ECG alert made non-cardiologists nearly twice as likely to start anticoagulation in AF patients at stroke risk. Randomised at the physician level and open-label in only two hospitals, with four co-primary endpoints of which two were met; the effective outcome population was the 275 vs 245 patients with AI-detected AF, and stroke and mortality were unchanged.